Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net income	$ 16,925	$ 17,339
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	328	350
Net amortization of investments	519	1,091
Change in investment related allowance for credit losses	(17)	(19)
Deferred income taxes	(369)	(19)
Net realized (gains) losses on investments	222	(258)
Net unrealized gains on equity securities	(4,776)	(1,369)
Share-based compensation	688	216
Changes in operating assets and liabilities:
Premiums receivable, net	(13,314)	(15,338)
Accrued interest receivable	24	(210)
Deferred policy acquisition costs	(1,019)	(1,228)
Other assets	(724)	320
Reserves for loss and loss adjustment expenses	(5,935)	(9,385)
Unearned premiums	7,703	9,127
Reinsurance balances	2,496	7,249
Amounts held for others and policyholder deposits	1,482	759
Federal income taxes payable/recoverable	4,141	3,987
Accounts payable and other liabilities	(868)	854
Net cash provided by operating activities	7,506	13,466
Investing activities
Purchases of investments held-to-maturity	(3,320)	(2,638)
Purchases of investments available-for-sale	0	(27,243)
Purchases of short-term investments	(38,559)	(21,358)
Proceeds from maturities of investments held-to-maturity	12,692	10,932
Proceeds from sales and maturities of investments available-for-sale	24,216	8,705
Proceeds from sales of equity securities	0	262
Proceeds from sales and maturities of short-term investments	0	4,175
Purchases of property and equipment	(746)	(32)
Net cash used in investing activities	(5,717)	(27,197)
Financing activities
Finance lease purchases	(21)	(23)
Dividends to shareholders	(7,075)	(6,505)
Net cash used in financing activities	(7,096)	(6,528)
Change in cash and cash equivalents	(5,307)	(20,259)
Cash and cash equivalents at beginning of period	38,682	61,469
Cash and cash equivalents at end of period	$ 33,375	$ 41,210